OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study.

Toxins (Basel) · 2026 · PMC13029949 · PMID 41893566

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

These results are highly significant in a condition that often requires several therapeutic attempts and simultaneous treatment with different active compounds, also considering that these patients have a long history of failed treatments and experience a considerable level of disability [ 15 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.